Aug 1, 2018 Cerecor Announces First Patient Enrolled in Phase I Trial for Neurogenic Orthostatic Hypotension (nOH) in Parkinson’s Disease
Apr 2, 2018 Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017
